Skip to navigation Skip to content

Suspected COVID-19 and MS


In this article

Information about people living with multiple sclerosis who have also been diagnosed with coronavirus (COVID-19) is still limited. However, the National MS Society is sharing what we know, what we don’t know and what we are striving to learn so that we get to the answers people with MS need as quickly as possible

Effects of COVID-19 on People Living with MS

Not much is yet known about people living with MS who have also been diagnosed COVID-19. The disease course and mortality rate are still being studied. Most information is only anecdotal data right now, meaning there are only individual reports of people with MS who have gotten the virus.

COVID-19 Registries for People Living with MS

Researchers across the globe are working to learn more about COVID-19 as quickly as possible. Recently, two registries launched in the United States to help people with MS and their providers share insights. Learn more about these registries. There are also registries in the United Kingdom, Italy and Australia

COVID-19 and Relapses

It is known that infections in general may provoke new symptoms or new MRI activity. As COVID-19 is an infection, it is possible that an MS relapse could occur. Sometimes a fever can provoke a temporary worsening of old symptoms. If you are concerned about your symptoms, please contact your MS provider.

COVID-19 Vaccine for People Living with MS

There are several vaccines for COVID-19 in early clinical trials, but any vaccine will not be available for several months. When a vaccine is available, it will be important for all people, including those living with MS, to consider getting it. Please note, certain DMTs could affect the timing of vaccine administration.

Treatments for COVID-19 in People with MS

There are no drugs approved for the treatment of COVID-19, but the FDA has authorized the use of some treatments for those who meet specific criteria. If someone with MS gets COVID-19 and meets the criteria to use an authorized drug, it will be prescribed. Individual risks, including current use of a DMT, will need to be considered in this decision making.

To learn more about emergency use authorization (EUA), please watch this video from the FDA.

COVID-19 Screening for People Living with MS

People with MS do not necessarily get priority screening for COVID-19. If you are experiencing any symptoms of COVID-19 please contact your primary care provider for guidance right away. Be sure to tell your provider of any medications you take, including a DMT.

Additional Resources



En Español

Estamos observando de cerca la situación del coronavirus (COVID-19) y tomando decisiones sobre la mejor manera de actuar en esta situación sin precedente.

Aprende Más

Aprende Más

The National MS Society is Here to Help

Need More Information?

We Are Here

Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online.

Contact Us

Contact Us

Weekly Webinars

The Ask an MS Expert weekly webinar series is an opportunity to learn more about multiple sclerosis from top MS experts.

Learn More

Learn More

© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.